Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant declines » significant decline (Expand Search), significantly declined (Expand Search), significant nonlinear (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
Showing 2,001 - 2,020 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant declines) OR (significant genes)) decrease ))', query time: 0.51s Refine Results
  1. 2001
    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects.

    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2002
    Demographic characteristics of the breast cancer patients enrolled in the study.

    Demographic characteristics of the breast cancer patients enrolled in the study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2003
    FPRP values for the association between rs12529 and breast cancer risk.

    FPRP values for the association between rs12529 and breast cancer risk. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2004
    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH).

    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2005
    Representative restriction enzyme-digested products on a 2% agarose gel.

    Representative restriction enzyme-digested products on a 2% agarose gel. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2006
    Baseline characteristics of study subjects.

    Baseline characteristics of study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2007
    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).

    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2008
    Functional effects of rs12529 (H5Q) on the AKR1C3 protein.

    Functional effects of rs12529 (H5Q) on the AKR1C3 protein. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2009
    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.

    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2010
    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.

    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2011
    The clinicopathological information of the patients involved in this study.

    The clinicopathological information of the patients involved in this study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2012
    Genotypic distribution of rs12529 in the study subjects.

    Genotypic distribution of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2013
    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2014
    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2015
    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period.

    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2016
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2017
    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya.

    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2018
    Uganda: enrolment, time to IVA, mortality, admissions and readmissions.

    Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2019
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2020
    Bluetooth beacons with colour coded lanyards.

    Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: